Whilst the importance of DARPP‐32, t‐DARPP and the ratio thereof in tumourigenesis remains to be fully understood, evidence in breast cancer implies that DARPP‐32 plays a role in inhibiting cell growth, whilst t‐DARPP accelerates it. This evidence concerns the gene PPP1R1B and breast carcinoma.